# FDA Inspection 1167954 - Izun Pharmaceuticals Corporation - April 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/izun-pharmaceuticals-corporation/050addb3-ad44-42fd-95ee-e7dbb5f08b68
Source feed: FDA_Inspections

> FDA Inspection 1167954 for Izun Pharmaceuticals Corporation on April 11, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167954
- Company Name: Izun Pharmaceuticals Corporation
- Inspection Date: 2022-04-11
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1167954 - 2022-04-11](https://www.keypedia.com/records/fda_inspections/izun-pharmaceuticals-corporation/237879f1-ea16-4768-92d9-c47e8bb73937)
- [FDA Inspection 1036992 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/izun-pharmaceuticals-corporation/b2e1ca10-6be2-4ab7-badd-a15f948e83ad)
- [FDA Inspection 1036992 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/izun-pharmaceuticals-corporation/8a812d18-968a-499c-bd4a-cf98b4e6156b)

Company: https://www.keypedia.com/companies/izun-pharmaceuticals-corporation/2db172e4-4e27-4f22-8b37-766e9c833203

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7